Epstein Secrets

nate Majority Leader McConnell "of not wanting a deal at all, while one Republican senator called the new GOP bill 'a mess." Reuters (7/28, Morgan, Zengerle) reports Trump "told reporters that there were aspects of the bill hammered out with fellow Republicans and unveiled on Monday that he did not like.

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

health-coronavirus-usa-congress/senate-republicans-push-back-on- mcconnells-1 -trillion-u-s-coronavirus-relief-proposal-idUSKCN24T1AZ> (7/28, Morgan, Zengerle) reports Trump "told reporters that there were aspects of the bill hammered out with fellow Republicans and unveiled on Monday that he did not like

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

ate Majority Leader McConnell "of not wanting a deal at all, while one Republican senator called the new GOP bill `a mess." Reuters (7/28, Morgan, Zengerle) reports Trump "told reporters that there were aspects of the bill hammered out with fellow Republicans and unveiled on Monday that he did not like.

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U

ate Majority Leader McConnell "of not wanting a deal at all, while one Republican senator called the new GOP bill `a mess." Reuters (7/28, Morgan, Zengerle) reports Trump "told reporters that there were aspects of the bill hammered out with fellow Republicans and unveiled on Monday that he did not like.

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U